-
1
-
-
0242288797
-
Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland
-
Gibb DM, Duong T, Tookey PA et al. Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ 2003; 327: 1019-21.
-
(2003)
BMJ
, vol.327
, pp. 1019-1021
-
-
Gibb, D.M.1
Duong, T.2
Tookey, P.A.3
-
2
-
-
4444315072
-
Metabolic complications of HIV therapy in children
-
McComsey G, Leonard E. Metabolic complications of HIV therapy in children. AIDS 2004; 18: 1753-68.
-
(2004)
AIDS
, vol.18
, pp. 1753-1768
-
-
McComsey, G.1
Leonard, E.2
-
3
-
-
0026655617
-
Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells
-
Gang Y, Hansson GK, Holme E. Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 1992; 71 1268-76.
-
(1992)
Circ Res
, vol.71
, pp. 1268-1276
-
-
Gang, Y.1
Hansson, G.K.2
Holme, E.3
-
4
-
-
15444370727
-
HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis
-
Perry SW, Norman JP, Litzburg A et al. HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis. J Immunol 2005; 174: 4333-44.
-
(2005)
J Immunol
, vol.174
, pp. 4333-4344
-
-
Perry, S.W.1
Norman, J.P.2
Litzburg, A.3
-
5
-
-
0026028226
-
Depletion of mitochondrial, DNA in AIDS patients with zidovudine-induced myopathy
-
Arnaudo E, Dalakas M, Shanske S et al. Depletion of mitochondrial, DNA in AIDS patients with zidovudine-induced myopathy. Lancet 1991; 337: 508-10.
-
(1991)
Lancet
, vol.337
, pp. 508-510
-
-
Arnaudo, E.1
Dalakas, M.2
Shanske, S.3
-
6
-
-
37548999884
-
Complications associated with NRTI therapy: Update on clinical features and possible pathogenic mechanisms
-
Nolan D, Mallal S. Complications associated with NRTI therapy: Update on clinical features and possible pathogenic mechanisms. Antivir Ther 2005; 10: M53-64.
-
(2005)
Antivir Ther
, vol.10
-
-
Nolan, D.1
Mallal, S.2
-
7
-
-
0033604060
-
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
-
Blanche S, Tardieu M, Rustin P et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999; 354: 1084-9.
-
(1999)
Lancet
, vol.354
, pp. 1084-1089
-
-
Blanche, S.1
Tardieu, M.2
Rustin, P.3
-
8
-
-
33746125974
-
-
Joint United Nations Programme on HIV/AIDS, UNAIDS, 11 September 2007, date last accessed, www.unaids.org
-
Joint United Nations Programme on HIV/AIDS. Report on the Global HIV/ AIDS Epidemic. UNAIDS 2006. http://www.unaids.org://www.tinaids.org www.unaids.org (11 September 2007, date last accessed).
-
(2006)
Report on the Global HIV/ AIDS Epidemic
-
-
-
9
-
-
0029054718
-
Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: Pediatric AIDS Clinical Trials Group Protocol 076 - results and treatment recommendations
-
Connor EM, Mofenson LM. Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: Pediatric AIDS Clinical Trials Group Protocol 076 - results and treatment recommendations. Pediatr Infect Dis J 1995; 14: 536-41.
-
(1995)
Pediatr Infect Dis J
, vol.14
, pp. 536-541
-
-
Connor, E.M.1
Mofenson, L.M.2
-
11
-
-
34047239196
-
A brief overview of mechanisms of mitochondrial toxicity from NRTIs
-
Kohler J, Lewis W. A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environ Mol Mutagen 2007; 48: 166-72.
-
(2007)
Environ Mol Mutagen
, vol.48
, pp. 166-172
-
-
Kohler, J.1
Lewis, W.2
-
12
-
-
16844369889
-
Nuclear and mitochondrial DNA repair: Similar pathways?
-
Larsen NB, Rasmussen M, Rasmussen LJ. Nuclear and mitochondrial DNA repair: Similar pathways? Mitochondrion 2005; 5: 89-108.
-
(2005)
Mitochondrion
, vol.5
, pp. 89-108
-
-
Larsen, N.B.1
Rasmussen, M.2
Rasmussen, L.J.3
-
13
-
-
33646011542
-
Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naive patients
-
Maagard A, Holberg-Petersen M, Kvittingen EA et al. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naive patients. HIV Med 2006; 7: 53-8.
-
(2006)
HIV Med
, vol.7
, pp. 53-58
-
-
Maagard, A.1
Holberg-Petersen, M.2
Kvittingen, E.A.3
-
14
-
-
33745067485
-
Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: Evidence supporting the DNA pol γ hypothesis
-
Lewis W, Kohler JJ, Hosseini SH et al. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: Evidence supporting the DNA pol γ hypothesis. AIDS 2006; 20: 675-84.
-
(2006)
AIDS
, vol.20
, pp. 675-684
-
-
Lewis, W.1
Kohler, J.J.2
Hosseini, S.H.3
-
15
-
-
27144530639
-
Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS
-
Lewis W, Hasse CP, Miller YK et al. Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS. Lab Invest 2005; 85: 972-81.
-
(2005)
Lab Invest
, vol.85
, pp. 972-981
-
-
Lewis, W.1
Hasse, C.P.2
Miller, Y.K.3
-
16
-
-
10644291831
-
Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine
-
Miro O, Lopez S, Rodriguez de la Concepcion M et al. Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine. J Acquir Immune Defic Syndr 2004; 37: 1550-5.
-
(2004)
J Acquir Immune Defic Syndr
, vol.37
, pp. 1550-1555
-
-
Miro, O.1
Lopez, S.2
Rodriguez de la Concepcion, M.3
-
17
-
-
27444435995
-
The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection
-
Lo C, Kazemi MR, Hsue PY et al. The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection. Clin Infect Dis 2005; 41: 1341-2.
-
(2005)
Clin Infect Dis
, vol.41
, pp. 1341-1342
-
-
Lo, C.1
Kazemi, M.R.2
Hsue, P.Y.3
-
18
-
-
0033935975
-
Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity
-
Kakunda TN. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 2000; 22: 685-708.
-
(2000)
Clin Ther
, vol.22
, pp. 685-708
-
-
Kakunda, T.N.1
-
19
-
-
0037045058
-
Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse transcriptase inhibitors
-
Walker UA, Setzer B, Venhoff N. Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse transcriptase inhibitors. AIDS 2002; 16: 2165-73.
-
(2002)
AIDS
, vol.16
, pp. 2165-2173
-
-
Walker, U.A.1
Setzer, B.2
Venhoff, N.3
-
20
-
-
34247166580
-
Preventing mother to child transmission of HIV-1
-
Foster CJ, Lyall EGH. Preventing mother to child transmission of HIV-1. Paediatr Child Health 2007; 17: 126-31.
-
(2007)
Paediatr Child Health
, vol.17
, pp. 126-131
-
-
Foster, C.J.1
Lyall, E.G.H.2
-
21
-
-
4744374408
-
Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3′-azido-3′-deoxythymidine
-
Walker DM, Poirier MC, Campen MJ et al. Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3′-azido-3′-deoxythymidine. Cardiovasc Toxicol 2004; 4: 133-53.
-
(2004)
Cardiovasc Toxicol
, vol.4
, pp. 133-153
-
-
Walker, D.M.1
Poirier, M.C.2
Campen, M.J.3
-
22
-
-
9144232859
-
Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine
-
Gerschenson M, Nguyen V, Ewings EL et al. Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine. AIDS Res Hum Retroviruses 2004; 20 91-100.
-
(2004)
AIDS Res Hum Retroviruses
, vol.20
, pp. 91-100
-
-
Gerschenson, M.1
Nguyen, V.2
Ewings, E.L.3
-
23
-
-
27144536621
-
Cardiac mitochondrial compromise in 1-yr-old Erythrocebus palas monkeys perinatally-exposed to nucleoside reverse transcriptase inhibitors
-
Divi RL, Leonard SL, Kuo MM et al. Cardiac mitochondrial compromise in 1-yr-old Erythrocebus palas monkeys perinatally-exposed to nucleoside reverse transcriptase inhibitors. Cardiovasc Toxicol 2005; 5: 333-46.
-
(2005)
Cardiovasc Toxicol
, vol.5
, pp. 333-346
-
-
Divi, R.L.1
Leonard, S.L.2
Kuo, M.M.3
-
24
-
-
0034648743
-
Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group
-
Lipshultz SE, Easley KA, Orav EJ et al. Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med 2000; 343: 759-66.
-
(2000)
N Engl J Med
, vol.343
, pp. 759-766
-
-
Lipshultz, S.E.1
Easley, K.A.2
Orav, E.J.3
-
25
-
-
34047235999
-
Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity
-
Divi RL, Leonard SL, Kuo MM et al. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity. Environ Mol Mutagen 2007; 48: 201-9.
-
(2007)
Environ Mol Mutagen
, vol.48
, pp. 201-209
-
-
Divi, R.L.1
Leonard, S.L.2
Kuo, M.M.3
-
26
-
-
0037378552
-
Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy
-
Shiramizu B, Shikuma KM, Kamemoto L et al. Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. J Acquir Immune Defic Syndr 2003; 32: 370-4.
-
(2003)
J Acquir Immune Defic Syndr
, vol.32
, pp. 370-374
-
-
Shiramizu, B.1
Shikuma, K.M.2
Kamemoto, L.3
-
27
-
-
0038078685
-
Women and Infants Transmission Study (WITS) Group. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers
-
Poirier MC, Divi RL, Al-Harthi L et al. Women and Infants Transmission Study (WITS) Group. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. J Acquir Immune Defic Syndr 2003; 33: 175-83.
-
(2003)
J Acquir Immune Defic Syndr
, vol.33
, pp. 175-183
-
-
Poirier, M.C.1
Divi, R.L.2
Al-Harthi, L.3
-
28
-
-
0042232027
-
Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: Clinical screening in a large prospective cohort
-
For the French Perinatal Cohort Study Group
-
Barret B, Tardieu M, Rustin P et al. For the French Perinatal Cohort Study Group. Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: Clinical screening in a large prospective cohort. AIDS 2003; 17: 1769-85.
-
(2003)
AIDS
, vol.17
, pp. 1769-1785
-
-
Barret, B.1
Tardieu, M.2
Rustin, P.3
-
29
-
-
0034319154
-
Nucleoside exposure in the children of HIV infected women receiving antiretroviral drugs: Absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States Cohorts
-
The Perinatal Safety Review Working Group
-
The Perinatal Safety Review Working Group. Nucleoside exposure in the children of HIV infected women receiving antiretroviral drugs: Absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States Cohorts. J Acquir Immune Defic Syndr 2000; 25: 261-8.
-
(2000)
J Acquir Immune Defic Syndr
, vol.25
, pp. 261-268
-
-
-
30
-
-
0037379462
-
Exposure to antiretroviral therapy in utero or early life: The health of uninfected children born to HIV-infected women
-
European Collaborative Study
-
European Collaborative Study. Exposure to antiretroviral therapy in utero or early life: The health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr 2003; 32: 380-7.
-
(2003)
J Acquir Immune Defic Syndr
, vol.32
, pp. 380-387
-
-
-
31
-
-
34247609876
-
In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children
-
Brogly SB, Ylitato N, Mofenson LM et al. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children. AIDS 2007; 21: 929-38.
-
(2007)
AIDS
, vol.21
, pp. 929-938
-
-
Brogly, S.B.1
Ylitato, N.2
Mofenson, L.M.3
-
32
-
-
0035947340
-
Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission
-
Giaquinto C, De Romeo A, Giacomet V et al. Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission. AIDS 2001; 15: 1074-5.
-
(2001)
AIDS
, vol.15
, pp. 1074-1075
-
-
Giaquinto, C.1
De Romeo, A.2
Giacomet, V.3
-
33
-
-
0141459353
-
Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy
-
Alimenti A, Burdge DR, Ogilvie GS et al. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy. Pediatr Infect Dis J 2003; 22: 782-9.
-
(2003)
Pediatr Infect Dis J
, vol.22
, pp. 782-789
-
-
Alimenti, A.1
Burdge, D.R.2
Ogilvie, G.S.3
-
34
-
-
21844444330
-
European Collaborative Study. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers
-
Bunders M, Thorne C, Newell ML; European Collaborative Study. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS 2005; 19: 1071-9.
-
(2005)
AIDS
, vol.19
, pp. 1071-1079
-
-
Bunders, M.1
Thorne, C.2
Newell, M.L.3
-
35
-
-
33646570846
-
Mitochondrial disease in the offspring as a result of antiretroviral therapy
-
Venhoff N, Walker UA. Mitochondrial disease in the offspring as a result of antiretroviral therapy. Expert Opin Drug Saf 2006; 5: 373-81.
-
(2006)
Expert Opin Drug Saf
, vol.5
, pp. 373-381
-
-
Venhoff, N.1
Walker, U.A.2
-
36
-
-
34247132084
-
Long-term follow-up of uninfected children born to HIV-infected women and exposed to antiretroviral therapy: Survey of parents' and health professionals' views
-
Hankin CD, Newell ML, Tookey P. Long-term follow-up of uninfected children born to HIV-infected women and exposed to antiretroviral therapy: Survey of parents' and health professionals' views. AIDS Care 2007; 4: 482-6.
-
(2007)
AIDS Care
, vol.4
, pp. 482-486
-
-
Hankin, C.D.1
Newell, M.L.2
Tookey, P.3
-
37
-
-
23044453130
-
Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy
-
Haugaard SB, Andersen O, Madsbad S et al. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy. J Med Virol 2005; 77: 29-38.
-
(2005)
J Med Virol
, vol.77
, pp. 29-38
-
-
Haugaard, S.B.1
Andersen, O.2
Madsbad, S.3
-
38
-
-
33748103186
-
Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients
-
Maagaard A, Holberg-Petersen M, Kollberg G et al. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients. Antivir Ther 2006; 11: 601-8.
-
(2006)
Antivir Ther
, vol.11
, pp. 601-608
-
-
Maagaard, A.1
Holberg-Petersen, M.2
Kollberg, G.3
-
39
-
-
10744222741
-
Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine
-
Walker UA, Bauerle J, Laguno M et al. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine. Hepatology 2004; 39: 311-7.
-
(2004)
Hepatology
, vol.39
, pp. 311-317
-
-
Walker, U.A.1
Bauerle, J.2
Laguno, M.3
-
40
-
-
0141458253
-
Mitochondrial toxicity in the era of HAART: Evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy
-
Montaner JS, Cote HC, Harris M et al. Mitochondrial toxicity in the era of HAART: Evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy. J Acquir Immune Defic Syndr 2003; 34 Suppl 1: S85-90.
-
(2003)
J Acquir Immune Defic Syndr
, vol.34
, Issue.SUPPL. 1
-
-
Montaner, J.S.1
Cote, H.C.2
Harris, M.3
-
41
-
-
19944426227
-
Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine
-
McComsey GA, Paulsen DM, Lonergan JT et al. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. AIDS 2005; 19: 15-23.
-
(2005)
AIDS
, vol.19
, pp. 15-23
-
-
McComsey, G.A.1
Paulsen, D.M.2
Lonergan, J.T.3
-
42
-
-
33745790291
-
Alliance Study Group. Enfuvirtide in HIV-1-infected individuals changing therapy to a nucleoside reverse transcriptase inhibitor sparing regimen: The ALLIANCE Study
-
Dwyer DE, Workman C, Hales G et al.; Alliance Study Group. Enfuvirtide in HIV-1-infected individuals changing therapy to a nucleoside reverse transcriptase inhibitor sparing regimen: The ALLIANCE Study. Antivir Ther 2006; 11: 409-19.
-
(2006)
Antivir Ther
, vol.11
, pp. 409-419
-
-
Dwyer, D.E.1
Workman, C.2
Hales, G.3
-
43
-
-
2342441341
-
Safety and efficacy of a NRTI-sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1-infected children
-
Fraaij PL, Neubert J, Bergshoeff AS et al. Safety and efficacy of a NRTI-sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1-infected children. Antivir Ther 2004; 9: 297-9.
-
(2004)
Antivir Ther
, vol.9
, pp. 297-299
-
-
Fraaij, P.L.1
Neubert, J.2
Bergshoeff, A.S.3
-
44
-
-
33751515147
-
Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment
-
El-Sadr WM, Lundgren JD, Neaton JD et al.; Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355: 2359-61.
-
(2006)
N Engl J Med
, vol.355
, pp. 2359-2361
-
-
El-Sadr, W.M.1
Lundgren, J.D.2
Neaton, J.D.3
-
45
-
-
27144527399
-
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: A prospective study
-
Mussini C, Pinti M, Bugarini R et al. Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: A prospective study. AIDS 2005; 19: 1627-33.
-
(2005)
AIDS
, vol.19
, pp. 1627-1633
-
-
Mussini, C.1
Pinti, M.2
Bugarini, R.3
-
46
-
-
3142707107
-
Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe
-
European Paediatric Lipodystrophy Group
-
European Paediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS 2004; 18: 1443-51.
-
(2004)
AIDS
, vol.18
, pp. 1443-1451
-
-
-
47
-
-
0036467615
-
Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy
-
Cossarizza A, Pinti M, Moretti L et al. Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy. J Infect Dis 2002; 185: 299-305.
-
(2002)
J Infect Dis
, vol.185
, pp. 299-305
-
-
Cossarizza, A.1
Pinti, M.2
Moretti, L.3
-
48
-
-
0034834856
-
Markers of cell death-activation in lymphocytes of vertically HIV-infected children naive to highly active antiretroviral therapy: The role of age
-
Vigano A, Pinti M, Nasi M et al. Markers of cell death-activation in lymphocytes of vertically HIV-infected children naive to highly active antiretroviral therapy: The role of age. J Allergy Clin Immunol 2001; 108: 439-45.
-
(2001)
J Allergy Clin Immunol
, vol.108
, pp. 439-445
-
-
Vigano, A.1
Pinti, M.2
Nasi, M.3
|